| Dr Elizabeth Ramsey Unal, MD | |
|
415 N 9th St, Ste 6w100, Springfield, IL 62702-5303 | |
| (217) 545-5117 | |
| (217) 545-4912 |
| Full Name | Dr Elizabeth Ramsey Unal |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 21 Years |
| Location | 415 N 9th St, Springfield, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043394729 | NPI | - | NPPES |
| 036118417 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036118417 (Illinois) | Secondary |
| 207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | 036-118417 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Siu Physicians And Surgeons Inc | 2365352820 | 275 |
News Archive
A collaboration between Portuguese and Italian scientists has discovered new subgroups of stomach cancer patients with different disease's characteristics, an information that is hoped will help improving the clinical management of a disease that still kills a dismaying 3 out of 4 patients.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
The Decker School of Nursing has received a two-year, $757,000 traineeship grant from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) to provide financial support for graduate students.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
Scientists may have discovered more reasons to love chocolate. A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially reversing the chronic inflammation and insulin resistance associated with obesity.
› Verified 1 days ago
| Entity Name | Siu Physicians & Surgeons Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558385989 PECOS PAC ID: 2365352820 Enrollment ID: O20031222000769 |
News Archive
A collaboration between Portuguese and Italian scientists has discovered new subgroups of stomach cancer patients with different disease's characteristics, an information that is hoped will help improving the clinical management of a disease that still kills a dismaying 3 out of 4 patients.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
The Decker School of Nursing has received a two-year, $757,000 traineeship grant from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) to provide financial support for graduate students.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
Scientists may have discovered more reasons to love chocolate. A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially reversing the chronic inflammation and insulin resistance associated with obesity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Ramsey Unal, MD Po Box 19640, Springfield, IL 62794-9640 Ph: (217) 545-5117 | Dr Elizabeth Ramsey Unal, MD 415 N 9th St, Ste 6w100, Springfield, IL 62702-5303 Ph: (217) 545-5117 |
News Archive
A collaboration between Portuguese and Italian scientists has discovered new subgroups of stomach cancer patients with different disease's characteristics, an information that is hoped will help improving the clinical management of a disease that still kills a dismaying 3 out of 4 patients.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
The Decker School of Nursing has received a two-year, $757,000 traineeship grant from the U.S. Department of Health and Human Services Health Resources and Services Administration (HRSA) to provide financial support for graduate students.
BG Medicine, Inc., a U.S. based, privately-held biomarker discovery and in vitro diagnostics company, announced today that there will be several data presentations regarding galectin-3 at the Heart Failure Congress 2010, the annual scientific meeting of the Heart Failure Association of the European Society of Cardiology, to be held in Berlin, Germany, on May 29th through June 1st. BG Medicine has developed and applied for FDA clearance of an in vitro diagnostic test to measure galectin-3 levels in plasma or serum.
Scientists may have discovered more reasons to love chocolate. A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially reversing the chronic inflammation and insulin resistance associated with obesity.
› Verified 1 days ago
Robert Marc Abrams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 415 N 9th St, 6w100, Springfield, IL 62702 Phone: 217-545-5117 Fax: 217-545-4912 | |
Jillian Henry, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 747 N Rutledge St, 2nd Floor, Springfield, IL 62702 Phone: 217-757-7932 Fax: 217-757-7920 | |
Grace Welp, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 415 N 9th St, Springfield, IL 62702 Phone: 217-545-8000 Fax: 217-545-7958 | |
Dr. Sara Beth Rubenacker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 415 N 9th St, Springfield, IL 62702 Phone: 217-545-5117 Fax: 217-545-4912 | |
Dustin Stehling, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 900 N 1st St, Springfield, IL 62702 Phone: 217-528-7541 | |
Nora Taylor Maczura, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 900 N 1st St, Springfield, IL 62702 Phone: 217-528-7541 Fax: 217-535-3665 |